View of Analysis of the regulatory scenario for the renewal of registration of generic and similar drugs at the National Health Surveillance Agency: subsidy to the health regulation of post-registration of drugs

Return to Article Details Analysis of the regulatory scenario for the renewal of registration of generic and similar drugs at the National Health Surveillance Agency: subsidy to the health regulation of post-registration of drugs Download Download PDF